Portugal has the highest incidence rate of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in Europe, and Montenegro has the lowest, recently published findings in the Clinical Kidney Journal show.
According to the 2012 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report, the overall unadjusted incidence and prevalence of patients receiving RRT for ESRD was 109.6 per million population (pmp) and 716.7 pmp (on December 31, 2012), respectively. The unadjusted incidence was 219.9 pmp in Portugal and 24.2 pmp in Montenegro. On December 31, 2012, Portugal also had the highest unadjusted prevalence (1670.2 pmp), and Ukraine had the lowest (146.7 pmp).
The ERA-EDTA Registry collected data from national and regional registries in 30 countries in Europe and from 20 other European countries without registries. The total coverage of the European population by the ERA-EDTA Registry was 71.3% in 2012.